Dr. Hu Bingshan, born in 1982, is an independent non-executive Director of our Company. He was appointed as an independent non-executive Director, a member of Audit Committee and a member of Nomination Committee of our Company on June 27, 2025 and is primarily responsible for supervising and providing independent judgment to our Board.
Dr. Hu has successively served as associate professor and professor at the University of Shanghai for Science and Technology (上海理工大学) since November 2016. His main research field is rehabilitation and nursing robotics. From October 2010 to November 2016, Dr. Hu worked as a space robotics systems engineer at the Shanghai Aerospace System Engineering Institute in the China Aerospace Science and Technology Corporation (中国航天科技集团公司上海宇航系统工程研究所). In 2015, he also served as a visiting scholar at the University of Hamburg in Germany. Dr. Hu serves as a committee member for the Sports Health and Industry Promotion Committee of China Association of Rehabilitation Medicine (中国康复医学会运动健康与产业发展专委会) and other relevant academic organizations. He received the First Prize and the Second Prize of Science and Technology from the China Association of Rehabilitation Medicine (中国康复医学会)in October 2023 and in September 2024, respectively. Dr. Hu has published more than 50 papers in internationally recognized journals or academic conferences. He is also an inventor or co-inventor of more than 70 Chinese and overseas patents.
Dr. Hu received his bachelor’s degree in electrical engineering and automation and his master’s degree in power electronics and electric drives from Harbin University of Science and Technology (哈尔滨理工大学) in July 2003 and April 2006, respectively, and obtained his Ph.D. in mechatronic engineering from Shanghai Jiao Tong University (上海交通大学)in December 2010.
©Copyright 1998-2023, MicroPort CardioFlow Medtech Corporation. All rights reserved. | 网站备案/许可证号:沪ICP备2023023560号 沪公网安备 31011502014876号
互联网药品信息服务资格证书编号:(沪)-非经营性 - 2024 - 0135
“MicroPort CardioFlow”及“ are registered trademarks of MicroPort CardioFlow Medtech Corporation.